NCT03594370

Brief Summary

Here the investigators proposed this study to collect cases of different etiologies of ocular surface diseases. With at least one of these four non-invasive examination modalities, the investigators aim to analyze and compare the detecting results. The investigators especially focus on the possibility of using OCT to predict the condition of limbal epithelial stem cells, aiming to use this patient-friendly tool to detect the patient's limbal conditions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 8, 2018

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

July 1, 2018

Completed
19 days until next milestone

First Posted

Study publicly available on registry

July 20, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 22, 2019

Completed
Last Updated

July 26, 2019

Status Verified

May 1, 2019

Enrollment Period

8 months

First QC Date

July 1, 2018

Last Update Submit

July 24, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • limbal structural abnormality

    atypical pattern of limbal Palisade of Vogt detected by OCT comparing to normal subjects

    assess the OCT limbal image at the baseline

Study Arms (3)

control

Limbal image by OCT in normal subjects.

Advancing wave-like epitheliopathy

Limbal image by OCT in subjects with advancing wave-like epitheliopathy.

Ocular rosacea or phlyctenulosis

Limbal image by OCT in subjects with ocular rosacea or phlyctenulosis

Eligibility Criteria

Age5 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Our study is an institutional observation study recruits otherwise healthy patients aging over 5 years old.

You may qualify if:

  • Patient who is able to understand and cooperate with the examination: aged over 5 years.
  • Patient or the legal representative is able to read and sign an informed consent form.
  • Patient with one of the diagnosis listed below:
  • limbal insufficiency
  • phlyctenulosis
  • ocular rosacea
  • ocular graft-versus-host disease (GVHD)
  • dry eye syndrome (both aqueous deficiency or increased evaporative forms of dry eyes)
  • other ocular surface diseases (advancing wave-like epitheliopathy, long term use of anti-glaucoma eye drops)

You may not qualify if:

  • Patients who decline to receive any of the non-invasive examinations mentions in this clinical trial.
  • Patients younger than 5 years old.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NTUH

Taipei, Taiwan

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Impression cytology(IC) is a technique which permits the retrieval of the outermost layer of ocular surface cells via the use of various types of filters. It is a minimally invasive method of evaluating human conjunctival epithelial cell morphology. IC may also be utilized in the diagnosis of other ocular diseases, such as ocular surface squamous neoplasia, ocular surface infections, keratoconus and thyroid orbitopathy. IC improves our understanding of the pathophysiology of ocular surface disease, and provide biomarkers to be used as outcome measures in clinical trials.

MeSH Terms

Conditions

Limbal Stem Cell Deficiency

Condition Hierarchy (Ancestors)

Corneal DiseasesEye Diseases

Study Officials

  • Wei-Li Chen

    NTUH

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 1, 2018

First Posted

July 20, 2018

Study Start

June 8, 2018

Primary Completion

January 31, 2019

Study Completion

May 22, 2019

Last Updated

July 26, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations